Africa’s biotech market set to reach $138.2 billion by 2030
The African biotechnology market is projected to reach $138.2 billion by 2030, according to the UN Economic Commission for Africa’s (UNECA) 2026 report—a milestone that marks a major strategic reorientation for the continent. The accelerated adoption of frontier technologies now extends beyond health emergencies, becoming a central instrument for economic planning and local resource valorisation.
The current structure of the sector’s current structure reveals a crucial complementarity for endogenous development.
Biopharmaceuticals dominate with 42% market share, while bio-industry (24%) and bio-agriculture (21%) offer direct levers for structural transformation.
This distribution allows African nations to tightly link scientific innovation with industrialisation and raw material processing on the continent.
The dramatic decline in genomic sequencing costs now operationally accessible to over half of African states enables immediate applications in agricultural modernisation, yield optimisation, and climate resilience, without ceding national sovereignty to foreign laboratories.
The impact of this technological transition on development hinges on public institutions’ ability to anchor innovations within rigorous state policies.
Technical mastery, demonstrated by emerging advanced infrastructure in South Africa and Kenya, proves that the continent possesses the necessary human capital.
The primary challenge now shifts to legislation: building protective legal frameworks for bioservices and bioinformatics while securing intellectual property against bio-piracy risks.
Harmonising standards across regional blocs is essential to accelerate genomic innovation adoption and guarantee collective food security.
By structuring this highly strategic market before the decade’s end, Africa definitively breaks with traditional technical assistance models, asserting a doctrine of scientific and industrial sovereignty capable of transforming its biological potential into national added value and geopolitical influence.
